Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6 months in a nonhuman primate neonate model

Ítems similars

• A novel R848-conjugated inactivated influenza virus vaccine is efficacious and safe in a neonate nonhuman primate model
  per: Holbrook, Beth C., et al.
  Publicat: (2016)
• Analysis of R848 as an Adjuvant to Improve Inactivated Influenza Vaccine Immunogenicity in Elderly Nonhuman Primates
  per: Kali F. Crofts, et al.
  Publicat: (2022-03-01)
• An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non‐human primate neonates
  per: Holbrook, Beth C., et al.
  Publicat: (2017)
• Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model
  per: Holbrook, Beth C., et al.
  Publicat: (2016)
• An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model
  per: Clemens, Elene A, et al.
  Publicat: (2020)